Ark Invest’s Brett Winton aims to replicate last quarter’s success with tech-heavy ETFs. Ark Innovation ETF surged 48% last quarter and Ark Space Exploration ETF was up 36%. Winton sees value in AI infrastructure and is bullish on fintech stocks. Ark Invest is betting big on innovation and transformation in various sectors.

Read more at CNBC

1. The FDA has approved a new Alzheimer’s drug, Aduhelm, despite controversy over its efficacy. Biogen, the drug’s developer, claims it can slow cognitive decline, while critics argue there is insufficient evidence.

2. Bitcoin’s price dropped below $30,000 for the first time in a month, highlighting the cryptocurrency’s volatility. This comes after China issued warnings about its use and Elon Musk’s tweets affected its value.

3. Amazon is acquiring MGM Studios for $8.45 billion, expanding its content library with popular franchises like James Bond. This move will strengthen Amazon’s position in the streaming market against competitors like Netflix and Disney+.: AI, Big Tech plays right now from Ark Invest’s top ranked ETFs